51. [Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents].
- Author
-
Firsova VA, Rusakova LI, Gubkina MF, Ryzhova AP, Panova LV, Kobulashvili MG, Poluéktova FG, and Iatskova TV
- Subjects
- Adolescent, Antitubercular Agents administration & dosage, Antitubercular Agents therapeutic use, Combined Modality Therapy, Drug Therapy, Combination, Humans, Hyaluronoglucosaminidase therapeutic use, Lasers, Magnetics, Treatment Outcome, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary therapy
- Abstract
The paper presents the follow-up data on 171 adolescents with active pulmonary tuberculosis. Extensive, complicated processes were encountered in 30% of patients. Chemotherapy was used in relation to the severity of disease, to the presence of decay and bacterial isolation, to the sensitivity of Mycobacteria tuberculosis. Most patients received routine treatment regimens including four (n = 66) or three (n = 51) drugs. The treatment involved auxiliary drugs (tarivid, protionamid, amykacin). Pathogenetic treatments (lidase therapy, laser blood radiation, magnetic therapy) were employed. Comorbidity was also treated. Good results were achieved in 95.4% of patients. Hospital treatment decreased by 1.5-3 months.
- Published
- 2001